WASHINGTON (AP) -- Government regulators said Wednesday they will ask a group of experts to review a new HIV drug from Merck and Co. in September. On Sept. 5, the Food and Drug Administration’s panel of antiviral drug experts plan to assess the safety and efficacy of Merck’s treatment Isentress, according to documents posted to the agency’s Web site.
